Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Annexin Pharmaceuticals AB (publ)

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 0 Equal arrow 0 More Arrow 1
Earnings before taxes -32,637 More Arrow -29,590 More Arrow -27,214
EBITDA -32,785 More Arrow -29,672 More Arrow -27,213
Total assets 12,363 More Arrow 17,976 More Arrow 24,510
Current assets 11,288 More Arrow 16,735 More Arrow 22,486
Current liabilities 3,457 More Arrow 5,339 Less Arrow 4,361
Equity capital 8,906 More Arrow 12,637 More Arrow 20,149
- share capital 5,729 Less Arrow 3,853 Less Arrow 1,709
Employees (average) 4 Equal arrow 4 More Arrow 5

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 72.0% Less Arrow 70.3% More Arrow 82.2%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -264.0% More Arrow -164.6% More Arrow -111.0%
Current ratio 326.5% Less Arrow 313.4% More Arrow 515.6%
Return on equity (ROE) -366.5% More Arrow -234.2% More Arrow -135.1%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 Less Arrow -1 More Arrow 0
Chg. No. of employees % 0% Less Arrow -20% More Arrow 0%

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.